Heron Therapeutics | HRTX - 現金と同等





現金と同等 変化する 日付
ALKERMES USD 351.55M 37.02M 2026-03
Alnylam Pharmaceuticals USD 1.71B 53.53M 2026-03
Amarin USD 131.06M 3.6M 2026-03
ANI Pharmaceuticals USD 285.58M 22.98M 2025-12
Anika Therapeutics USD 41.02M 16.46M 2026-03
Arrowhead Research USD 201.64M 112.94M 2025-12
Eisai JPY 301.65B 16.27B 2025-09
Emergent BioSolutions USD 111.7M 23.9M 2023-12
Esperion Therapeutics USD 92.45M 6.39M 2025-09
GlaxoSmithKline GBP 3.44B 292M 2026-03
Heron Therapeutics USD 43.07M 26.55M 2025-09
Insmed USD 510.44M 175.68M 2025-12
Ligand Pharmaceuticals USD 174.93M 489.59M 2025-12
Merck USD 5.33B 9.24B 2026-03
Nektar Therapeutics USD 15.12M 25.92M 2025-12
Neurocrine Biosciences USD 266.5M 446.5M 2026-03
Omeros USD 1.9M 2.36M 2025-06
Pacira USD 144.31M 14.24M 2026-03
Regeneron Pharmaceuticals USD 2.96B 15.9B 2026-03
Roche Holding CHF 7.55B 579M 2025-06
Sangamo BioSciences USD 38.34M 13.16M 2025-06
Surmodics USD 36.11M 11.81M 2024-09
Ultragenyx Pharmaceutical USD 421M 218.49M 2025-12
Veracyte USD 362.58M 47M 2025-12
Vertex Pharmaceuticals USD 7.25B 638.6M 2026-03